Fesler et al. demonstrated that restoring miR-15a expression in CRC cells suppresses tumor growth and enhances chemosensitivity by downregulating BCL2, along with other oncogenic targets such as BMI1 and YAP1. This evidence concerns the gene BMI1 and neoplasm.